Semaglutide

Description:

A once-weekly subcutaneous injection that supports blood sugar control and weight management. Works as a GLP-1 receptor agonist to regulate insulin secretion and reduce appetite.

MTI MEDICAL

Other Page

© 2019 MTI medical. All Rights Reserved

Find Us